Kjeld Schmiegelow

发表

TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

R. Pieters, A. Veerman, J. Harbott, 2000, Blood.

Cell proliferation is related to in vitro drug resistance in childhood acute leukaemia

A. Veerman, G. Henze, K. Schmiegelow, 2003, British Journal of Cancer.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

M. Relling, S. Yee, M. Carrillo, 2011, Clinical pharmacology and therapeutics.

A joint international consensus statement for measuring quality of survival for patients with childhood cancer

F. Aarsen, D. Mulrooney, D. Green, 2023, Nature Medicine.

A 10-year follow up of reproductive function in women treated for childhood cancer.

K. Schmiegelow, A. Andersen, E. Larsen, 2013, Reproductive biomedicine online.

6-Thioguanine nucleotide accumulation in erythrocytes during azathioprine treatment for systemic connective tissue diseases: a possible index for monitoring treatment.

K. Schmiegelow, N. J. Kriegbaum, Kjeld Schmiegelow, 1993, Annals of the rheumatic diseases.

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

T E Klein, M. Relling, C. Pui, 2011, Clinical pharmacology and therapy.

Increased risk of antidepressant use in childhood cancer survivors: a Danish population-based cohort study.

C. Johansen, S. Dalton, K. Schmiegelow, 2015, European journal of cancer.

Increasing incidence of childhood tumours of the central nervous system in Denmark, 1980–1996

O. Raaschou-Nielsen, M. Sørensen, K. Schmiegelow, 2006, British Journal of Cancer.